ASX - By Stock
|
IMM Biotech |
This is just beginning - immutep
|
|
ghostnz
|
0 |
223 |
18 |
16:57 |
16:57 |
ASX - By Stock
|
0
|
223
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Ceasing to be a substantial holder
|
|
ghostnz
|
11 |
4.8K |
6 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
11
|
4.8K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
1 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Hello
|
|
ghostnz
|
2 |
1.3K |
0 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
1 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Expansion of INSIGHT-003 trial for Efti in 1st Line NSCLC
|
|
ghostnz
|
9 |
3.9K |
0 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
9
|
3.9K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-003 trial 50% enrolment milestone has been achieved
|
|
ghostnz
|
8 |
6.3K |
0 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
8
|
6.3K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
1 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Fast Track granted by US FDA for Efti in 1st line NSCLC
|
|
ghostnz
|
26 |
13K |
0 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
26
|
13K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Fast Track granted by US FDA for Efti in 1st line NSCLC
|
|
ghostnz
|
26 |
13K |
0 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
26
|
13K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Clinical Development Update for Eftilagimod Alpha
|
|
ghostnz
|
12 |
5.6K |
3 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
12
|
5.6K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New investigator-initiated ph2 trial in Soft Tissue Sarcoma
|
|
ghostnz
|
9 |
3.6K |
0 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
9
|
3.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New investigator-initiated ph2 trial in Soft Tissue Sarcoma
|
|
ghostnz
|
9 |
3.6K |
0 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
9
|
3.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New investigator-initiated ph2 trial in Soft Tissue Sarcoma
|
|
ghostnz
|
9 |
3.6K |
2 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
9
|
3.6K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
1 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
1 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Marc or Mark, it's MARC
|
|
ghostnz
|
7 |
2.6K |
0 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
7
|
2.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
ghostnz
|
51 |
21K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
51
|
21K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
ghostnz
|
51 |
21K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
51
|
21K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
ghostnz
|
51 |
21K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
51
|
21K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
ghostnz
|
51 |
21K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
51
|
21K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
1 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
ghostnz
|
51 |
21K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
51
|
21K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
ghostnz
|
51 |
21K |
2 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
51
|
21K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
ghostnz
|
51 |
21K |
2 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
51
|
21K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ghostnz
|
2.6K |
1.0M |
0 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|